000 02377 a2200601 4500
005 20250517064433.0
264 0 _c20160920
008 201609s 0 0 eng d
022 _a1178-2005
024 7 _a10.2147/COPD.S89948
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSaito, Takefumi
245 0 0 _aTriple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treatment with tripLE.
_h[electronic resource]
260 _bInternational journal of chronic obstructive pulmonary disease
_c2015
300 _a2393-404 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Inhalation
650 0 4 _aAdrenergic beta-2 Receptor Agonists
_xadministration & dosage
650 0 4 _aAged
650 0 4 _aArea Under Curve
650 0 4 _aBronchodilator Agents
_xadministration & dosage
650 0 4 _aCholinergic Antagonists
_xadministration & dosage
650 0 4 _aCross-Over Studies
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aFluticasone-Salmeterol Drug Combination
_xadministration & dosage
650 0 4 _aForced Expiratory Volume
650 0 4 _aHumans
650 0 4 _aJapan
650 0 4 _aLung
_xdrug effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNebulizers and Vaporizers
650 0 4 _aPlethysmography
650 0 4 _aPredictive Value of Tests
650 0 4 _aPulmonary Disease, Chronic Obstructive
_xdiagnosis
650 0 4 _aROC Curve
650 0 4 _aRecovery of Function
650 0 4 _aSeverity of Illness Index
650 0 4 _aSpirometry
650 0 4 _aTime Factors
650 0 4 _aTiotropium Bromide
_xadministration & dosage
650 0 4 _aTreatment Outcome
650 0 4 _aVital Capacity
700 1 _aTakeda, Akinori
700 1 _aHashimoto, Katsuji
700 1 _aKobayashi, Akihiro
700 1 _aHayamizu, Tomoyuki
700 1 _aHagan, Gerald W
773 0 _tInternational journal of chronic obstructive pulmonary disease
_gvol. 10
_gp. 2393-404
856 4 0 _uhttps://doi.org/10.2147/COPD.S89948
_zAvailable from publisher's website
999 _c25483408
_d25483408